TREM2 sustains microglial expansion during aging and response to demyelination
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Microglia contribute to development, homeostasis, and immunity of the CNS. Like other tissue-resident macrophage populations, microglia express the surface receptor triggering receptor expressed on myeloid cells 2 (TREM2), which binds polyanions, such as dextran sulphate and bacterial LPS, and activates downstream signaling cascades through the adapter DAP12. Individuals homozygous for inactivating mutations in TREM2 exhibit demyelination of subcortical white matter and a lethal early onset dementia known as Nasu-Hakola disease. How TREM2 deficiency mediates demyelination and disease is unknown. Here, we addressed the basis for this genetic association using Trem2(-/-) mice. In WT mice, microglia expanded in the corpus callosum with age, whereas aged Trem2(-/-) mice had fewer microglia with an abnormal morphology. In the cuprizone model of oligodendrocyte degeneration and demyelination, Trem2(-/-) microglia failed to amplify transcripts indicative of activation, phagocytosis, and lipid catabolism in response to myelin damage. As a result, Trem2(-/-) mice exhibited impaired myelin debris clearance, axonal dystrophy, oligodendrocyte reduction, and persistent demyelination after prolonged cuprizone treatment. Moreover, myelin-associated lipids robustly triggered TREM2 signaling in vitro, suggesting that TREM2 may directly sense lipid components exposed during myelin damage. We conclude that TREM2 is required for promoting microglial expansion during aging and microglial response to insults of the white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the impaired ability of Trem2−/− or Apoe−/− microglia to remove damaged myelin hinders subsequent remyelination (Cantoni et al., 2015; Cantuti-Castelvetri et al., 2018; Poliani et al., 2015; Yeh et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 signals through its binding partner DAP12 (TYROBP) to elicit responses including phagocytosis, suppression of proinflammatory response, and promoting cell survival (Poliani et al., 2015; Takahashi et al., 2005).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 ligands include a variety of molecules, such as bacterial wall products, Aβ oligomers, lipoproteins, and anionic lipids, such as phospholipids and sphingolipids29,32–35”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is a phospholipid sensing receptor known to sustain microglial cell activation and expansion in response to demyelination or amyloid plaques in Alzheimer’s disease (AD) [8, 42, 50].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice lacking TREM2, fewer microglia accumulate in the corpus callosum during demyelination due to reduced proliferation which in turn reduces myelin debris clearance [200–202].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [201]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417 · cited 1×
“As DAP12 is located in lipid rafts, engagement of TREM2 may induce aggregation and mobilization of multiple receptors to lipid rafts (47), thereby facilitating their clustering and activation of multiple signaling pathways.”
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 2×
“As Trem2 –/– mice did not develop spontaneous demyelination, we wanted to determine been reported in CNS cells other than microglia (33, 34), recently published studies demonstrated that Trem2 is specifically expressed in microglia — but not other cells in the CNS — under steady-state conditions…”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2, R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 2×
“We recently demonstrated that human TREM2 detects a similarly broad range of anionic and zwitter-ionic lipid ligands (52).”
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2 , R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Cited by
Items 101–200 of 529
Lipid rafts as a therapeutic target
Sviridov, D., Mukhamedova, N., & Miller, Y. I. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr120000658 · Cited by 151
“(17), and assembly of the NADPH oxidase complex (18),”
BackgroundProtective Microglial Subset in Development, Aging, and Disease: Lessons From Transcriptomic Studies
Benmamar-Badel, A., Owens, T., & Wlodarczyk, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00430 · Cited by 124
“The data indicate that TREM2 deficiency had no impact on the initial demyelination, but affected subsequent remyelination when the cuprizone treatment was prolonged, most likely by impairing myelin removal as well as myelin regeneration, which further supports a protective role for CD11c+ microglia in this paradigm (1…”
BackgroundResultMicroglia in Alzheimer's Disease: Risk Factors and Inflammation
Katsumoto, A., Takeuchi, H., Takahashi, K., & Tanaka, F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00978 · Cited by 136
“Although the exact molecular mechanisms underlying the development of neurodegeneration in the brain remain unknown, abnormalities in TREM2 and its interacting partner DNAX activating protein of 12 kDa (DAP12) appear to cause dysregulation of microglial inflammatory responses and neuronal debris clearance (14, 15).”
BackgroundPinto, S., Cunha, C., Barbosa, M., Vaz, A. R., & Brites, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00273 · Cited by 135
“It is implicated in multiple microglial transcriptional programs causing microglial phenotypes that do not fit the conventional M1/M2 paradigm and cell expansion (Poliani et al., 2015).”
BackgroundMicroglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
Mhatre, S. D., Tsai, C. A., Rubin, A. J., James, M. L., & Andreasson, K. I. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.006 · Cited by 134
“TREM2 deficiency is also associated with impaired clearance of debris and prolonged demyelination after injury [20,21].”
Soluble TREM2: Innocent bystander or active player in neurological diseases?
Filipello, F., Goldsbury, C., You, S. F., Locca, A., Karch, C. M., & Piccio, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105630 · Cited by 134
Liang, K. J., & Carlson, E. S. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.01.004 · Cited by 143
Beckmann, N., Giorgetti, E., Neuhaus, A., Zurbruegg, S., Accart, N., Smith, P., Perdoux, J., Perrot, L., Nash, M., Desrayaud, S., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0510-8 · Cited by 131
“expressed on myeloid cells 2 protein) knock-out animals where microglia impairment could be observed by us and others [4, 40].”
Microglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging
Condello, C., Yuan, P., & Grutzendler, J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.007 · Cited by 131
“169 This suggests that TREM2 deficiency may affect additional mechanisms independent of 170 amyloid phagocytosis or plaque encapsulation, such as efficient corpse removal of 171 dying cells(52, 72) or degenerating myelin(50, 51), or additional unknown TREM2 172 functions.”
Microglia: Key Players in Retinal Ageing and Neurodegeneration
Guo, L., Choi, S., Bikkannavar, P., & Cordeiro, M. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.804782 · Cited by 126
“This sensitivity is achieved by the presence of microglial surface receptors which receive signals from surrounding neurons and the extracellular matrix that may indicate a homeostatic imbalance (Raivich et al., 1999; Nimmerjahn et al., 2005).”
BackgroundMicroglial phagocytosis in aging and Alzheimer's disease
Gabandé‐Rodríguez, E., Keane, L., & Capasso, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24419 · Cited by 127
“Thus, TREM‐2 knockout mice undergoing demyelination fail to up‐ regulate genes involved in expansion, clustering and phagocytosis (Cantoni et al., 2015; Poliani et al., 2015).”
BackgroundEsparza-Baquer, A., Labiano, I., Sharif, O., Agirre-Lizaso, A., Oakley, F., Rodrigues, P. M., Zhuravleva, E., O'Rourke, C. J., Hijona, E., Jimenez-Agüero, R., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319227 · Cited by 125
“12 However, its impact on cancer, 13–15 55 and particularly HCC, is almost unknown.”
Qiu, S., Palavicini, J. P., Wang, J., Gonzalez, N. S., He, S., Dustin, E., Zou, C., Ding, L., Bhattacharjee, A., Van Skike, C. E., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00488-7 · Cited by 125
Microglial Phenotypes and Functions in Multiple Sclerosis
O’Loughlin, E., Madore, C., Lassmann, H., & Butovsky, O. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028993 · Cited by 124
“Microglia density in the CNS tissue increases with age (Poliani et al. 2015), but a subset of these cells inhumans, highlyexpressing ferritin, shows signs of dystrophy or senescence, characterized by a reduction and beading of cell processes (Lopes et al.”
BackgroundDifferential contribution of microglia and monocytes in neurodegenerative diseases
Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1795-7 · Cited by 123
“In the cuprizone-induced mouse model of demyelination, Trem2 deficiency rendered microglia defective in clearing myelin debris, which resulted in a persistent demyelination (Cantoni et al. 2015; Poliani et al. 2015).”
BackgroundXia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E., Dugas, J., Pizzo, M. E., DeVos, S. L., Earr, T. K., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00547-7 · Cited by 124
Prokop, S., Miller, K. R., Labra, S. R., Pitkin, R. M., Hoxha, K., Narasimhan, S., Changolkar, L., Rosenbloom, A., Lee, V. M.-Y., & Trojanowski, J. Q. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02048-2 · Cited by 119
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
Zysset, D., Weber, B., Rihs, S., Brasseit, J., Freigang, S., Riether, C., Banz, Y., Cerwenka, A., Simillion, C., Marques-Vidal, P. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13151 · Cited by 130
Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells
Shirotani, K., Hori, Y., Yoshizaki, R., Higuchi, E., Colonna, M., Saito, T., Hashimoto, S., Saito, T., Saido, T. C., & Iwata, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-43535-6 · Cited by 116
Self-citationAPOE genotype and sex affect microglial interactions with plaques in Alzheimer’s disease mice
Stephen, T. L., Cacciottolo, M., Balu, D., Morgan, T. E., LaDu, M. J., Finch, C. E., & Pike, C. J. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0729-z · Cited by 115
Brekk, O. R., Honey, J. R., Lee, S., Hallett, P. J., & Isacson, O. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003021117 · Cited by 114
Macrophage senescence in health and diseases
Wang, L., Hong, W., Zhu, H., He, Q., Yang, B., Wang, J., & Weng, Q. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.01.008 · Cited by 130
“Additionally, microglia from the aged mice (24 months) increased a lot in corpus callosum and cerebellum 123 .”
BackgroundThe Phagocytic Code Regulating Phagocytosis of Mammalian Cells
Cockram, T. O. J., Dundee, J. M., Popescu, A. S., & Brown, G. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629979 · Cited by 113
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano-Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 91
Neuroprotective Effect of TREM-2 in Aging and Alzheimer’s Disease Model
Raha, A. A., Henderson, J. W., Stott, S. R. W., Vuono, R., Foscarin, S., Friedland, R. P., Zaman, S. H., & Raha-Chowdhury, R. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160663 · Cited by 111
Huang, P., Zhang, Z., Zhang, P., Feng, J., Xie, J., Zheng, Y., Liang, X., Zhu, B., Chen, Z., Feng, S., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03713-0 · Cited by 111
A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese
Jiang, T., Tan, L., Chen, Q., Tan, M.-S., Zhou, J.-S., Zhu, X.-C., Lu, H., Wang, H.-F., Zhang, Y.-D., & Yu, J.-T. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.023 · Cited by 110
“On ligand binding, TREM2 was revealed to regulate several important microglial functions including expansion, phagocytosis, and cytokines production (Jiang et al., 2014; Poliani et al., 2015).”
BackgroundDistinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
Yao, H., Coppola, K., Schweig, J. E., Crawford, F., Mullan, M., & Paris, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00457 · Cited by 110
Neuronal integrity and complement control synaptic material clearance by microglia after CNS injury
Norris, G. T., Smirnov, I., Filiano, A. J., Shadowen, H. M., Cody, K. R., Thompson, J. A., Harris, T. H., Gaultier, A., Overall, C. C., & Kipnis, J. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20172244 · Cited by 109
“Further, the phagocytic receptor TREM2 was shown to be critical for efficient removal of myelin debris after cuprizone-mediated demyelination (Poliani et al., 2015).”
BackgroundThe Molecular Basis for Remyelination Failure in Multiple Sclerosis
Gruchot, J., Weyers, V., Göttle, P., Förster, M., Hartung, H.-P., Küry, P., & Kremer, D. (2019) · Cells · doi:10.3390/cells8080825 · Cited by 109
“Long-term studies of TREM2 knockout mice showed impaired myelin debris clearance, axonal dystrophy, oligodendrocyte reduction, and persistent demyelination after prolonged cuprizone treatment [104].”
BackgroundLipid rafts in glial cells: role in neuroinflammation and pain processing
Miller, Y. I., Navia-Pelaez, J. M., Corr, M., & Yaksh, T. L. (2020) · Journal of Lipid Research · doi:10.1194/jlr.tr119000468 · Cited by 112
“Intrathecal administration of TREM2 agonistic antibody induces pro-inflammatory cytokine expression and neuropathic pain; this effect is abrogated in DAP12-deficient mice (61).”
BackgroundBar, E., & Barak, B. (2019) · Glia · doi:10.1002/glia.23637 · Cited by 107
“Microglia are also involved in myelin debris clearance in normal aging (Shobin et al., 2017) and in disease conditions, as shown in cuprizone-induced demyelination models (Poliani et al., 2015; Skripuletz et al., 2010).”
BackgroundMiao, J., Chen, L., Pan, X., Li, L.-Q., Zhao, B., & Lan, J. X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01376-y · Cited by 129
TREM2 triggers microglial density and age-related neuronal loss
Linnartz‐Gerlach, B., Bodea, L., Klaus, C., Ginolhac, A., Halder, R., Sinkkonen, L., Walter, J., Colonna, M., & Neumann, H. (2019) · Glia · doi:10.1002/glia.23563 · Cited by 104
“Another study in TREM2-deficient mice already demonstrated that TREM2 sustains microglial expansion during aging because 24 months old TREM2-deficient mice had fewer microglia in the corpus callosum, cerebellum and hippocampus (Poliani et al., 2015).”
BackgroundSelf-citationCx3cr1- deficient microglia exhibit a premature aging transcriptome
Gyoneva, S., Hosur, R., Gosselin, D., Zhang, B., Ouyang, Z., Cotleur, A. C., Peterson, M., Allaire, N., Challa, R., Cullen, P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900453 · Cited by 103
“Microgliaundergosubstantialchangesin gene expression and morphology with age (Poliani et al, 2015; Grabert et al, 2016; Olah et al, 2018), but it is not known whether the changes in microglia occur as a consequence of aging or help drive the process.”
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Guo, Y., Wei, X., Yan, H., Qin, Y., Yan, S., Liu, J., Zhao, Y., Jiang, F., & Lou, H. (2019) · The FASEB Journal · doi:10.1096/fj.201900992r · Cited by 101
Vascular dementia: A microglia's perspective
Yang, Y. R., Zhao, X., Zhu, Z., & Zhang, L. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101734 · Cited by 118
TREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment
Jay, T. R., von Saucken, V. E., Muñoz, B., Codocedo, J. F., Atwood, B. K., Lamb, B. T., & Landreth, G. E. (2019) · Glia · doi:10.1002/glia.23664 · Cited by 97
Gabandé‐Rodríguez, E., Pérez‐Cañamás, A., Soto‐Huelin, B., Mitroi, D. N., Sánchez‐Redondo, S., Martínez‐Sáez, E., Venero, C., Peinado, H., & Ledesma, M. D. (2019) · The EMBO Journal · doi:10.15252/embj.201899553 · Cited by 94
“Myelin-associated lipids such as SM promote phagocytosis and lipid catabolism in microglia (Turnbull et al , 2006; Poliani et al , 2015).”
Jendresen, C., Årskog, V., Daws, M. R., & Nilsson, L. N. G. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0835-4 · Cited by 94
“Since ApoE is a lipid carrier, the ApoE/TREM2 interaction is likely to be involved in lipid sensing by TREM2 [78, 89], although we hereby demonstrate that the nonlipidated ApoE protein is sufficient for a high-affinity interaction.”
BackgroundTREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
Zheng, H., Cheng, B., Li, Y., Li, X., Chen, X., & Zhang, Y.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00395 · Cited by 94
“Studies using solid-state ELISA or TREM2 reporter cells support the concept of phospholipids as TREM2 ligands, including phosphatidylethanolamine (PE), phosphatidylserine (PS), and cardiolipin, phosphatidylcholine (PC) or sphingomyelin (SM; Cannon et al., 2012; Poliani et al., 2015; Wang et al., 2015).”
BackgroundHan, X., Cheng, X., Xu, J., Liu, Y., Zhou, J., Jiang, L., Gu, X., & Xia, T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109231 · Cited by 110
Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
Zhong, J., Xing, X., Gao, Y., Pei, L., Lu, C., Sun, H., Lai, Y., Du, K., Xiao, F., Yang, Y., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.05.001 · Cited by 109
Sariol, A., Mackin, S., Allred, M.-G., Ma, C., Zhou, Y., Zhang, Q., Zou, X., Abrahante, J. E., Meyerholz, D. K., & Perlman, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007814117 · Cited by 97
“Trem2 expression is additionally required for optimal expression of Igf1 and remyelination (66).”
BackgroundInfluentialPatir, A., Shih, B., McColl, B. W., & Freeman, T. C. (2019) · Glia · doi:10.1002/glia.23572 · Cited by 90
“Given that the majority of microglial genes maintain their expression with age (Galatro et al., 2017; Jyothi et al., 2015; Poliani et al., 2015), we made the assumption that the average expression of the signature genes, can be used as a proxy for microglia number through aging.”
BackgroundVps35-dependent recycling of Trem2 regulates microglial function
Yin, J., Liu, X., He, Q., Zhou, L., Yuan, Z., & Zhao, S. (2016) · Traffic · doi:10.1111/tra.12451 · Cited by 90
“microglial expanse during aging and impaired myelin debris clearance in Cuprizone-induced nonautoimmune demyelination model.(5) Genomewide association study (GWAS) has identified R47H mutation of Trem2 increases the risk of Alzheimer’s disease (AD) with a high odds ratio (3.”
Phagocytic astrocytes: Emerging from the shadows of microglia
Konishi, H., Koizumi, S., & Kiyama, H. (2022) · Glia · doi:10.1002/glia.24145 · Cited by 88
“which are thought to be exposed on damaged myelin (Poliani et al., 2015; Y. Wang et al., 2015).”
BackgroundMicroenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury
Alizadeh, A., & Karimi‐Abdolrezaee, S. (2016) · The Journal of Physiology · doi:10.1113/jp270895 · Cited by 102
“As an example, IL-10 is shown to increase NPC migration (Guan et al. 2008), improve their neuronal and oligodendrocyte differentiation (Yang et al. 2009), and improve remyelination in experimental autoimmune encephalomyelitis (Pluchino & Martino, 2005; Butovsky et al. 2006) (Fig.”
BackgroundInfluentialHou, J., Zhou, Y., Cai, Z., Terekhova, M., Swain, A., Andhey, P. S., Guimaraes, R. M., Ulezko Antonova, A., Qiu, T., Sviben, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112293 · Cited by 85
“86,87,90 Hence, we speculate that the defects emanating from Trem2 deficiency hamper removal of myelin debris, which causes a secondary delay in the stress response of oligodendrocytes, preserving their homeostatic configuration.”
Self-citationShifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84
“It is becoming increasingly evident that the central role of TREM2 is not restricted to AD, but is also a key feature in many other neurological and peripheral disorders, such as stroke, multiple sclerosis (MS), metabolic disorders, response to infection or neuropathic pain (Cantoni et al., 2015; Correale et al., 2013…”
BackgroundMicroglial Homeostasis Requires Balanced CSF-1/CSF-2 Receptor Signaling
Chitu, V., Biundo, F., Shlager, G. G. L., Park, E. S., Wang, P., Gulinello, M. E., Gokhan, Ş., Ketchum, H. C., Saha, K., DeTure, M. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.028 · Cited by 83
Xue, T., Ji, J., Sun, Y., Huang, X., Cai, Z., Yang, J., Guo, W., Guo, R., Cheng, H., & Sun, X. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.012 · Cited by 82
Song, S., Yu, L., Hasan, M. N., Paruchuri, S. S., Mullett, S. J., Sullivan, M. L. G., Fiesler, V. M., Young, C. B., Stolz, D. B., Wendell, S. G., et al. (2022) · Communications Biology · doi:10.1038/s42003-021-02984-4 · Cited by 83
Simon, E., Obst, J., & Gomez-Nicola, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.059 · Cited by 83
Xu, J., Zhang, L., Li, M., He, X., Luo, J., Wu, R., Hong, Z., Zheng, H., & Hu, X. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02741-w · Cited by 88
“Discussion Biologically, TREM2 is involved in switching microglial functional state, clearance of myelin fragments [10, 24], as well as promotion of neurological recovery.”
BackgroundWang, N., Wang, M., Jeevaratnam, S., Rosenberg, C., Ikezu, T. C., Shue, F., Doss, S. V., Alnobani, A., Martens, Y. A., Wren, M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00577-1 · Cited by 82
“Deficiency of TREM2 has been shown to impair microglial functions by reducing their phagocytic ability [49, 73, 105].”
BackgroundFilipello, F., You, S.-F., Mirfakhar, F. S., Mahali, S., Bollman, B., Acquarone, M., Korvatska, O., Marsh, J. A., Sivaraman, A., Martinez, R., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02568-y · Cited by 81
“The TREM2 receptor has been shown to bind bacterial components [19], anionic and zwitterionic lipids [102], and myelin [88]; yet, the endogenous ligand remains poorly defined.”
BackgroundMicroglia: origins, homeostasis, and roles in myelin repair
Lloyd, A. F., Davies, C. L., & Miron, V. E. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.10.001 · Cited by 80
Dicer Deficiency Differentially Impacts Microglia of the Developing and Adult Brain
Varol, D., Mildner, A., Blank, T., Shemer, A., Barashi, N., Yona, S., David, E., Boura-Halfon, S., Segal-Hayoun, Y., Chappell-Maor, L., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.003 · Cited by 81
Puntambekar, S. S., Saber, M., Lamb, B. T., & Kokiko-Cochran, O. N. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.033 · Cited by 76
“Additionally, while the loss of TREM2 does not alter the capacity of microglia to phagocytose and degrade Aβ and apoptotic cells in 8 month old 5XFAD mice (41) , TREM2 is required for the internalization of fibrillar Aβ by microglia isolated from 4 month old 5XFAD;TREM2 +/+ mice (42) and for the phagocytic clearance o…”
BackgroundMicroglia Express Mu Opioid Receptor: Insights From Transcriptomics and Fluorescent Reporter Mice
Maduna, T., Audouard, E., Dembélé, D., Mouzaoui, N., Reiss, D. J., Massotte, D., & Gavériaux‐Ruff, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00726 · Cited by 79
Lee, S.-H., Rezzonico, M. G., Friedman, B. A., Huntley, M. H., Meilandt, W. J., Pandey, S., Chen, Y.-J. J., Easton, A., Modrusan, Z., Hansen, D. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110158 · Cited by 78
González Ibanez, F., Picard, K., Bordeleau, M., Sharma, K., Bisht, K., & Tremblay, M.-È. (2019) · Journal of Visualized Experiments · doi:10.3791/60510 · Cited by 77
Diversity and Function of Glial Cell Types in Multiple Sclerosis
Schirmer, L., Schafer, D. P., Bartels, T., Rowitch, D. H., & Calabresi, P. A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.01.005 · Cited by 76
Morris, G., Puri, B. K., & Frye, R. E. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0077-2 · Cited by 77
Guglielmetti, C., Le Blon, D., Santermans, E., Salas-Perdomo, A., Daans, J., De Vocht, N., Shah, D., Hoornaert, C., Praet, J., Peerlings, J., et al. (2016) · Glia · doi:10.1002/glia.23053 · Cited by 76
“Along with the secretion of anti-inflammatory factors, growth factors and neurotrophic factors, there is accumulating evidence that phagocytosis of myelin debris is an essential step for a successful remyelination and that this step is ensured by alternatively activated polarized microglia and macrophages (Cantoni et…”
BackgroundGeloso, M. C., & D’Ambrosi, N. (2021) · Cells · doi:10.3390/cells10030686 · Cited by 81
“Furthermore, in the cuprizone-induced model of demyelination Trem2−/− mice have been shown to exhibit an accumulation of myelin debris, increased axonal dystrophy and persistent demyelination [116,117].”
BackgroundThe cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
West, P. K., McCorkindale, A. N., Guennewig, B., Ashhurst, T. M., Viengkhou, B., Hayashida, E., Jung, S. R., Butovsky, O., Campbell, I. L., & Hofer, M. J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02441-x · Cited by 86
“The upregulation of these genes allow microglia to react to perturbation, enabling them to phagocytose damaged cells and other material (Axl, C1qa, C1qb) [130–134], interact and communicate with recruited lymphocytes (B2m, Cd274, H2-D1) [135, 136], process and metabolize myelin debris and other detritus (Ch25h, Lpl) […”
BackgroundDanger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease
Chiarini, A., Armato, U., Hu, P., & Prà, I. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239036 · Cited by 81
“Regarding brain neurodegenerative diseases, AD included, abundant evidences show that TREM2 knockout or hemizygous TREM2 or deficient DAP12/TYROBP significantly alters microglia’s behavior, intensifying its proinflammatory cytokines production, neuroinflammatory responses, and neuronal debris clearing activity [90,97,…”
BackgroundDistinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
Lee, E., Eo, J.-C., Lee, C., & Yu, J.-W. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0060 · Cited by 71
“Triggering receptor expressed on myeloid cells 2 (TREM2) is a crucial transmembrane receptor in microglia to scavenge extracellular toxic molecules such as amyloid-β and its expression is restricted to some CNS regions (Poliani et al., 2015; Schmid et al., 2002).”
BackgroundCadiz, M. P., Jensen, T. D., Sens, J. P., Zhu, K., Song, W.-M., Zhang, B., Ebbert, M., Chang, R., & Fryer, J. D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00531-1 · Cited by 73
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation
Matt, S. M., & Johnson, R. W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.009 · Cited by 73
“TREM2 deficiency produced fewer microglia with an abnormal morphology in aged mice, particularly in the corpus callosum, which is rich in myelin and may provide a major stimulus for TREM2 signaling [38].”
BackgroundLoss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice
Qu, W., & Li, L. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2193-20.2020 · Cited by 72
“Studies have shown that TREM2-deficient microglia fail to promote transcriptional changes and lipid metabolism in response to demyelination (Poliani et al., 2015; Nugent et al., 2020).”
BackgroundCoelho, I., Duarte, N., Barros, A., Macedo, M. P., & Penha-Gonçalves, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616044 · Cited by 70
“These observations are in line with reports of reduced survival of Trem-2 KO microglia cells during neurodegenerative processes (17, 39).”
ResultTREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57024-0 · Cited by 74
Self-citationTrem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V. S., Lin, P. B. C., Pennington, T., Di Prisco, G. V., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00409-0 · Cited by 70
Xue, F., & Du, H. (2021) · Cells · doi:10.3390/cells10020321 · Cited by 67
“Additionally, the functions of Trem2-dependent DAM may include depolarization, differentiation, and chemotaxis of microglia [79,80].”
Emre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 70
“Additionally, increased levels of TREM-2 correlate with microglial proliferation, as indicated by decreased numbers of microglia after injury in TREM-2 and DAP12 (ligand for TREM-2) knock-out mouse models [37, 68].”
BackgroundTREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00834-z · Cited by 97
“At the transcriptomic level, microglia from TREM2-deficient animals fail to upregulate genes related to activation, phagocytosis, and lipid metabolism, impairing lysosomal and phagosomal function, disrupting oxidative phosphorylation, and altering cholesterol metabolism [76–78].”
Immune cell modulation of oligodendrocyte lineage cells
Harrington, E. P., Bergles, D. E., & Calabresi, P. A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134601 · Cited by 73
“In the context of cuprizone-mediated demyelination, Trem2 knockout mice exhibited impaired myelin clearance, persistent demyelination and microglia that failed to upregulate transcripts involved in phagocytosis, activation and lipid metabolism [74].”
BackgroundBrain Parenchymal and Extraparenchymal Macrophages in Development, Homeostasis, and Disease
Brioschi, S., Zhou, Y., & Colonna, M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900821 · Cited by 68
Self-citationCentral nervous system diseases related to pathological microglial phagocytosis
Wang, K., Li, J., Zhang, Y., Huang, Y., Chen, D., Shi, Z., Smith, A. D., Li, W., & Gao, Y. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13619 · Cited by 69
Joost, E., Jordão, M. J. C., Mages, B., Prinz, M., Bechmann, I., & Krueger, M. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01834-8 · Cited by 66
Sato-Hashimoto, M., Nozu, T., Toriba, R., Horikoshi, A., Akaike, M., Kawamoto, K., Hirose, A., Hayashi, Y., Nagai, H., Shimizu, W., et al. (2019) · eLife · doi:10.7554/elife.42025 · Cited by 65
The CNS mononuclear phagocyte system in health and disease
Mundt, S., Greter, M., & Becher, B. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.005 · Cited by 71
Central nervous system demyelinating diseases: glial cells at the hub of pathology
Costa, V. G. C., Espírito‐Santo, S., Alves‐Leon, S. V., & Gomes, F. C. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135540 · Cited by 76
A mouse model for testing remyelinating therapies
Bai, C. B., Sun, S., Roholt, A., Benson, E., Edberg, D., Medicetty, S., Dutta, R., Kidd, G., Macklin, W. B., & Trapp, B. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.033 · Cited by 65
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript al., 2014; Poliani et al., 2015; Stidworthy et al., 2003).”
BackgroundThe Unique Phenotype of Lipid-Laden Macrophages
van Eijk, M., & Aerts, J. M. F. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084039 · Cited by 63
“In the absence of TREM-2, the DAM in MS fail to induce the gene program to optimally handle the lipid load, and, consequently, unfavorable cholesterol ester accumulation occurs [52,96].”
Retinal and brain microglia in multiple sclerosis and neurodegeneration
Choi, S., Guo, L., & Cordeiro, M. F. (2021) · Cells · doi:10.3390/cells10061507 · Cited by 63
“TREM2 are expressed on microglial cell surface membranes; however, its deficiency or mutation can result in disease caused by excessive demyelination [50].”
BackgroundWang, Q., Wang, Y., Liu, J., Sutphen, C. L., Cruchaga, C., Blazey, T., Gordon, B. A., Su, Y., Chen, C., Shimony, J. S., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101767 · Cited by 63
Self-citationBehavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
Kang, S. S., Kurti, A., Baker, K. E., Liu, C.-C., Colonna, M., Ulrich, J. D., Holtzman, D. M., Bu, G., & Fryer, J. D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx366 · Cited by 62
“As TREM2 has been shown to impact microglial expansion during aging and has been shown to impact survival in both macrophages and microglia, it is possible that behavioral and cognitive readouts would be different in an aged cohort of Trem2 / mice (44,45,49).”
BackgroundSelf-citationReformulating Pro-Oxidant Microglia in Neurodegeneration
García-Revilla, J., Alonso-Bellido, I. M., Burguillos, M. A., Herrera, A. J., Espinosa-Oliva, A. M., Ruiz, R., Cruz-Hernández, L., García-Domínguez, I., Roca-Ceballos, M. A., Santiago, M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101719 · Cited by 62
“However, new interesting candidates could be products associated with Aβ plaques, including Aβ itself [75,76], several lipoproteins like APOE and CLU/APOJ [77], phosphatidylinositol, and phosphatidylcholine [43,78].”
BackgroundWang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 66
Effect of glial cells on remyelination after spinal cord injury
Liu, B., Wang, Y.-Y., Wang, H., Liu, X.-K., Li, R., Zhang, P., Chu, Z., Wang, C., Liu, H.-R., Qi, J., et al. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.217354 · Cited by 72
“A previous study reported that this microglial function is dependent on downstream activation of the DAP12 signaling pathway by triggering receptor expressed on myeloid cells 2 (TREM2) (Poliani et al., 2015).”
BackgroundSelf-citationGaucher disease: Basic and translational science needs for more complete therapy and management
Grabowski, G. A., Antommaria, A. H. M., Kolodny, E. H., & Mistry, P. K. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.12.291 · Cited by 64
Zhou, Y., Tada, M., Cai, Z., Andhey, P. S., Swain, A., Miller, K. R., Gilfillan, S., Artyomov, M. N., Takao, M., Kakita, A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-022-01403-y · Cited by 69
Self-citationThe GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment
Toro, C., Zainab, M., & Tifft, C. J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136195 · Cited by 63
“These events not only affect neurons, but also microglia, astrocytes, and oligodendrocytes [54-57].”
Exploring the Impact of TREM2 in Tumor-Associated Macrophages
Khantakova, D., Brioschi, S., & Molgora, M. (2022) · Vaccines · doi:10.3390/vaccines10060943 · Cited by 75
“Trem2-deficient mice exhibited accumulation of intracellular cholesterol in brain microglia during demyelination [36,43], along with defective myelin repair in the central nervous system (CNS) white matter [40,41,44,45].”
BackgroundSiddiqui, T. A., Lively, S. S., & Schlichter, L. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0531-9 · Cited by 67
“TREM2 senses lipid components of damaged myelin, is required for debris clearance, and is mainly expressed on microglia [47].”
Background
Metadata
- Authors
- Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M.
- Affiliations
- University of Brescia (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Poliani, Pietro Luigi
- Wang, Yaming
- Colonna, Marco
- Venue
- Journal of Clinical Investigation
- Published
- 2015-04-20
- Volume
- 125
- Issue
- 5
- Pages
- 2161-2170
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4463196
- OpenAlex
- W2094831055
- Cited by
- 525
- References
- 58
- Citations by year
- 2026: 45 · 2025: 41 · 2024: 41 · 2023: 55 · 2022: 69 · 2021: 65 · 2020: 50 · 2019: 43 · 2018: 40 · 2017: 32 · 2016: 32 · 2015: 10
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, public-domain)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Eli Lilly and Company
- Cure Alzheimer's Fund
- Fondazione Cariplo
- National Institutes of Health (5p60dk020579-35, AG005681, DK020579)
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis
- Japan Society for the Promotion of Science (15K20969, 26893063)
- RIKEN
- National Institute on Aging (P50AG005681)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK‐020579, P60-DK-020579, P30DK020579)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- TREM2, microglia, aging, demyelination, cuprizone, myelin debris clearance, white matter, oligodendrocyte degeneration, myelin lipids, Nasu-Hakola disease, TREM2 knockout mice, microglial activation, phagocytosis, lipid degradation, axonal dystrophy
- MeSH terms
- Aging, Animals, Axons, Brain, Cell Count, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Lipodystrophy, Membrane Glycoproteins, Myelin Sheath, Nerve Tissue Proteins, Osteochondrodysplasias, Phagocytosis, Receptors, Immunologic, Regeneration, Subacute Sclerosing Panencephalitis, Transcription, Genetic, Microglia, Genes, Reporter, Mice, Knockout, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.